This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Comment: How Apple’s US antitrust court battle with Epic Games will unfold

By Michael Acton and Amy Miller ( April 21, 2021, 22:58 GMT | Comment) -- Rarely are antitrust cases more high-stakes or more high-profile than Apple’s US court battle with Epic Games – and as if that wasn’t enough, it’s taking place against the backdrop of a global pandemic. On May 3, the two companies will begin a grueling three-week trial, with the fate of Apple’s lucrative App Store business model hinging on the decision of US District Judge Yvonne Gonzalez Rogers in California. Covid-19 has created unique technical challenges for conducting the trial, but the terms of access to the court, and questions of how the trial itself will unfold, are now clearer. Rarely are antitrust cases more high-stakes or more high-profile than Apple’s US court battle with Epic Games – and as if that wasn’t enough, it’s taking place against the backdrop of a global pandemic....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections